CD38 and neoplasm: CD38 degrades circulating NAD and its precursors NMN and NR, preventing NAD synthesis.123 CD38 and NAD regulate T-cell phenotypes and responses.138 Expressed by immune and tumor cells, CD38 is involved in the activation and mobilization of intracellular Ca2+ signaling through the cADPR/NAADP metabolite product.